Welcome!
The APOS 9th Annual Conference will be held at the Hyatt Regency Miami, 23 - 25 February 2012. The Scientific Program Committee is planning another great educational conference. We hope to see you there!
The APOS conference is uniquely designed to improve translation of research to practice in psychosocial oncology, bringing together researchers and practitioners to develop, test and implement innovative approaches to psychosocial supportive care for people undergoing cancer treatment and/or moving into survivorship.
Keynote Speaker
APOS is pleased to host
keynote speaker, Bruce D. Rapkin, PhD. Dr. Rapkin has pioneered
research designs and assessment methodology to promote
evidence-based interventions through academic-community
collaboration that improve access to quality of life and care among
diverse, medically underserved patients, families and
communities.
The 16th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma provides a unique opportunity for medical oncologists, hematologists, and other health care professionals to learn from and to interact with international leaders in the field of hematologic malignancies in order to increase knowledge, apply new data, and practice and improve patient outcomes.
Dear Colleague,
We invite you to join us in the beautiful city of Amsterdam, 24-26 February 2012, to attend the 8th European Congress on Hematologic Malignancies: From Clinical Science to Clinical Practice.
In its eight year, the Congress encompasses hematologic malignancies, including myeloma, lymphoma, and leukemia, as well as discussions on screening, diagnosis and the latest management options. The focus of the 2012 Congress is to provide a forum to review state-of-the-art and present new data, as well as give attendees the opportunity to exchange ideas with world-renowned opinion leaders in the field.
The Annual EAU Congress is a platform for the international urological community to share the latest and the most relevant knowledge with medical experts practising across the board.
7. ročník kurzu se v roce 2012 uskuteční v Lipsku.
Konference je zaměřena na nové postupy v radiační onkologii a na postavení radioterapie v multidisciplinární onkologické léčbě.
The congress will feature presentations
on multi disciplinary research, in addition to related educational
sessions. The program will offer an opportunity for clinically
relevant, in depth discussions of today’s science that will impact
treatment now and in the near future.
Téma: Vzácné nádory- Sarkomy měkkých tkání, GIST, NET, nádory štítné žlázy, vzácné nádory ledvin, Ewing/PNET, epiteloidní hemangioendoteliom, anální karcinom, feochromocytom.
Pozor, změna termínu! původní termín: 8. - 9. 3. 2012 byl z technických důvodů změněn na 13. - 14. 3. 2012.
Due to the exciting developments of molecular biology during the past decade and our increasing understanding of the mechanisms relevant to the genesis of cancer, we are experiencing a transition from disease to target-oriented therapy. This has a strong impact on the development paradigm of cancer therapeutics. Nowhere is this more apparent than in molecular targeted therapy. As with previous meetings, BTOC-11 will focus on the clinical development of a broad spectrum of anti-cancer agents attracting a multi-stakeholder attendance connecting preclinical and clinical scientists, clinicians, healthcare professionals, academia, industry and other stakeholders who are involved in the development of novel anti-cancer agents.
The NCCN Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ draws oncologists from private practice, government, and academic settings; oncology fellows, nurses, pharmacists; and other cancer health care providers from across the United States and around the globe. Conference attendees learn about the latest NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) and new cancer therapies. There will be roundtable discussions featuring leading professionals from academic, clinical, industry, and business realms of cancer care.
Konference je zaměřena na problematiku onko-gynekologie. Každý rok má jako nosné téma jiný zhoubný novotvar. Tématem pro rok 2012 je karcinom děložního těla.
This conference is directed toward researchers and clinicians interested in state-of-the-art information related to the most current and ongoing research examining issues of cognition and cancer.
The goal of this conference is to present and discuss current research examining the impact of cancer and cancer-related treatment on cognitive and behavioral functioning in adults with non-central nervous system cancers. Presentations will focus on state-of-the-art research elucidating the nature of the cognitive and neurobehavioral sequelae associated with cancer and cancer therapies, the mechanisms that underlie these changes in function, and interventions to prevent or manage these undesired symptoms and/or their side effects.
